Frequently Asked Questions
The market is segmented based on , By Disorder (Macular Degeneration, Diabetic Eye Disease, Retinal Detachment, Retinoblastoma, Macular Pucker, Macular Hole, Floaters), Disorder Type (Genetic, Age Related), Treatment Techniques (Laser, Freezing, Implanting, Indenting, Pneumatic Retinopexy, Scleral Buckling, Vitrectomy), Route of Administration (Oral, Topical, Intravitreal, Others), End-Users (Hospitals, Ambulatory Surgical Centers, Home Healthcare, Others), Distribution Channel (Direct Tender, Hospital Pharmacy, Retail Pharmacy, Online Pharmacy, Others) - Industry Trends and Forecast to 2030.
.
The Global Retinal Disease Therapeutics Market size was valued at USD 12.57 USD Billion in 2022.
The Global Retinal Disease Therapeutics Market is projected to grow at a CAGR of 9.3% during the forecast period of 2023 to 2030.
The market report covers data from the U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E., South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
